Jackson, Grant Investment Advisers, Inc. Gilead Sciences, Inc. Transaction History
Jackson, Grant Investment Advisers, Inc.
- $269 Million
- Q2 2025
A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 1,105 shares of GILD stock, worth $133,119. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,105
Previous 1,104
0.09%
Holding current value
$133,119
Previous $123,000
0.81%
% of portfolio
0.05%
Previous 0.05%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.46MPut Options Held
9.94M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.17 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.58 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.45 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $151B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...